002424 logo

Guizhou Bailing Group Pharmaceutical Co., Ltd. Stock Price

SZSE:002424 Community·CN¥6.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

002424 Share Price Performance

CN¥0
-4.25 (-100.00%)
CN¥0
-4.25 (-100.00%)
Price CN¥0

002424 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Good value with adequate balance sheet.

2 Risks
2 Rewards

Guizhou Bailing Group Pharmaceutical Co., Ltd. Key Details

CN¥3.2b

Revenue

CN¥1.5b

Cost of Revenue

CN¥1.6b

Gross Profit

CN¥1.6b

Other Expenses

CN¥2.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 24, 2026
0.0016
52.35%
0.071%
35.7%
View Full Analysis

About 002424

Founded
1999
Employees
6586
CEO
Min Niu
WebsiteView website
www.gzbl.com

Guizhou Bailing Group Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells medicines in China. It operates through four segments: Industrial, Commerce, Medical institutions, and Others The company offers medicines in various forms, including tablets, capsules, granules, syrups, powders, pills, dews, pastes, sprays, and oral liquids, as well as wines and honey. Its products are used for cardiovascular, cough, cold, gynecological, and pediatric areas. The company was incorporated in 1999 and is headquartered in Anshun, China.

Recent 002424 News & Updates

Recent updates

No updates